Cite
HARVARD Citation
Xiao, A. et al. (n.d.). 403Ceftolozane/Tazobactam (C/T) Dose Optimization in Patients with End Stage Renal Disease (ESRD) Requiring Hemodialysis (HD) Using Population Pharmacokinetics (pPK) and Monte Carlo Simulations (MCS). Open forum infectious diseases. pp. S155-S156. [Online].